Last edition
News about "biosimilar medicines "
Amneal Completes Kashiv BioSciences Acquisition to Strengthen Biosimilars Business
Amneal has completed its acquisition of Kashiv BioSciences, creating an integrated global biosimilar platform spanning R&D, manufacturing and commercialisation.
Biosimilar Medicines | 11/08/2026 | By News Bureau
Biocon Biologics and Civica to Expand Insulin Aspart Access in US
Civica will commercialize the medicine for patients in the United States, after completion of development work and clinical trials. No technology transfer is involved in the agreement.
Biosimilar Medicines | 10/03/2025 | By Aishwarya | 467
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy